| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC32A1 TRPM4 ABCA2 SLC25A18 SLC7A13 CHRNA9 SLC35D2 SLC16A14 KCNJ10 SCN4A SLC22A10 SCN8A SLC15A5 SLCO1B3 SLC47A1 TRPM8 NMUR2 NIPAL3 SLCO1B1 CHRM5 ABCA8 SLC16A12 CHRND ATP6V0A2 SLC5A2 XPR1 SLC52A3 | 3.02e-12 | 1180 | 94 | 27 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | SLC32A1 TRPM4 ABCA2 SLC25A18 SLC7A13 CHRNA9 SLC35D2 SLC16A14 KCNJ10 SCN4A SLC22A10 SCN8A SLC15A5 SLCO1B3 SLC47A1 TRPM8 ATP10B NMUR2 NIPAL3 SLCO1B1 CHRM5 ABCA8 SLC16A12 CHRND ATP6V0A2 SLC5A2 XPR1 SLC52A3 | 3.72e-12 | 1289 | 94 | 28 | GO:0005215 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC32A1 ABCA2 SLC25A18 SLC7A13 SLC35D2 SLC16A14 SLC22A10 SLC15A5 SLCO1B3 SLC47A1 SLCO1B1 ABCA8 SLC16A12 ATP6V0A2 SLC5A2 XPR1 | 7.26e-10 | 477 | 94 | 16 | GO:0022804 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC32A1 SLC25A18 SLC7A13 SLC35D2 SLC16A14 SLC22A10 SLC15A5 SLCO1B3 SLC47A1 SLCO1B1 SLC16A12 SLC5A2 XPR1 | 1.32e-09 | 296 | 94 | 13 | GO:0015291 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | TPRA1 OR4C3 GALR1 OR4A8 OR6S1 OR4Q2 OR4A5 OR10H2 TAS2R36 NPSR1 OR4M1 OR4K5 NMUR2 TAS2R30 TAS2R46 CHRM5 OR10X1 OR52A1 OR4K14 | 2.43e-08 | 884 | 94 | 19 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | TPRA1 OR4C3 GALR1 CHRNA9 OR4A8 OR6S1 OR4Q2 OR4A5 IL1R2 OR10H2 TAS2R36 NPSR1 OR4M1 OR4K5 RET NMUR2 TAS2R30 TAS2R46 CHRM5 OR10X1 OR52A1 OR4K14 CHRND | 5.02e-08 | 1353 | 94 | 23 | GO:0004888 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC32A1 SLC25A18 SLC7A13 SLC35D2 SLC16A14 SLC22A10 SLCO1B3 SLC47A1 SLCO1B1 SLC16A12 SLC52A3 | 1.32e-07 | 293 | 94 | 11 | GO:0008514 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | SLC32A1 SLC25A18 SLC7A13 SLC16A14 SLC22A10 SLCO1B3 SLC47A1 SLCO1B1 SLC16A12 | 5.77e-07 | 207 | 94 | 9 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | SLC32A1 SLC25A18 SLC7A13 SLC16A14 SLC22A10 SLCO1B3 SLC47A1 SLCO1B1 SLC16A12 | 6.01e-07 | 208 | 94 | 9 | GO:0005342 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC32A1 TRPM4 SLC25A18 CHRNA9 KCNJ10 SCN4A SCN8A SLC47A1 TRPM8 NMUR2 NIPAL3 CHRM5 ATP6V0A2 SLC5A2 XPR1 | 2.43e-06 | 758 | 94 | 15 | GO:0015318 |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 4.19e-06 | 90 | 94 | 6 | GO:0008028 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC32A1 TRPM4 SLC25A18 CHRNA9 KCNJ10 SCN4A SCN8A SLC47A1 TRPM8 NMUR2 NIPAL3 CHRM5 CHRND ATP6V0A2 SLC5A2 | 4.22e-06 | 793 | 94 | 15 | GO:0015075 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR4C3 OR4A8 OR6S1 OR4Q2 OR4A5 OR10H2 OR4M1 OR4K5 OR10X1 OR52A1 OR4K14 | 5.76e-06 | 431 | 94 | 11 | GO:0004984 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC32A1 TRPM4 SLC25A18 CHRNA9 KCNJ10 SCN4A SCN8A SLC47A1 TRPM8 NIPAL3 CHRND ATP6V0A2 SLC5A2 | 1.37e-05 | 664 | 94 | 13 | GO:0008324 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 3.56e-05 | 193 | 94 | 7 | GO:0015276 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC32A1 TRPM4 SLC25A18 CHRNA9 KCNJ10 SCN4A SCN8A SLC47A1 TRPM8 NIPAL3 ATP6V0A2 SLC5A2 | 3.77e-05 | 627 | 94 | 12 | GO:0022890 |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 4.05e-05 | 197 | 94 | 7 | GO:0022834 | |
| GeneOntologyMolecularFunction | sodium-independent organic anion transmembrane transporter activity | 7.83e-05 | 18 | 94 | 3 | GO:0015347 | |
| GeneOntologyMolecularFunction | anandamide 8,9 epoxidase activity | 1.31e-04 | 4 | 94 | 2 | GO:0062187 | |
| GeneOntologyMolecularFunction | anandamide 11,12 epoxidase activity | 1.31e-04 | 4 | 94 | 2 | GO:0062188 | |
| GeneOntologyMolecularFunction | bitter taste receptor activity | 2.72e-04 | 27 | 94 | 3 | GO:0033038 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 3.13e-04 | 459 | 94 | 9 | GO:0005216 | |
| GeneOntologyMolecularFunction | amino acid:proton symporter activity | 3.25e-04 | 6 | 94 | 2 | GO:0005280 | |
| GeneOntologyMolecularFunction | anandamide 14,15 epoxidase activity | 3.25e-04 | 6 | 94 | 2 | GO:0062189 | |
| GeneOntologyMolecularFunction | anandamide epoxidase activity | 3.25e-04 | 6 | 94 | 2 | GO:0062186 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 3.29e-04 | 196 | 94 | 6 | GO:0005319 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 3.52e-04 | 71 | 94 | 4 | GO:0015179 | |
| GeneOntologyMolecularFunction | taste receptor activity | 4.98e-04 | 33 | 94 | 3 | GO:0008527 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 5.25e-04 | 140 | 94 | 5 | GO:0099094 | |
| GeneOntologyMolecularFunction | symporter activity | 7.18e-04 | 150 | 94 | 5 | GO:0015293 | |
| GeneOntologyMolecularFunction | channel activity | 8.23e-04 | 525 | 94 | 9 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 8.34e-04 | 526 | 94 | 9 | GO:0022803 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.01e-03 | 334 | 94 | 7 | GO:0022836 | |
| GeneOntologyMolecularFunction | amide transmembrane transporter activity | 1.02e-03 | 42 | 94 | 3 | GO:0042887 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 1.09e-03 | 43 | 94 | 3 | GO:0005231 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.18e-03 | 343 | 94 | 7 | GO:0005261 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.53e-03 | 105 | 94 | 4 | GO:0015171 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.58e-03 | 465 | 94 | 8 | GO:0046873 | |
| GeneOntologyMolecularFunction | sodium channel activity | 1.89e-03 | 52 | 94 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | prostaglandin transmembrane transporter activity | 1.92e-03 | 14 | 94 | 2 | GO:0015132 | |
| GeneOntologyMolecularFunction | phosphatidate phosphatase activity | 1.92e-03 | 14 | 94 | 2 | GO:0008195 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 2.00e-03 | 53 | 94 | 3 | GO:0008188 | |
| GeneOntologyMolecularFunction | icosanoid transmembrane transporter activity | 2.21e-03 | 15 | 94 | 2 | GO:0071714 | |
| GeneOntologyMolecularFunction | oligopeptide transmembrane transporter activity | 2.52e-03 | 16 | 94 | 2 | GO:0035673 | |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 2.85e-03 | 17 | 94 | 2 | GO:0022848 | |
| GeneOntologyMolecularFunction | lipid phosphatase activity | 3.56e-03 | 19 | 94 | 2 | GO:0042577 | |
| GeneOntologyMolecularFunction | sphingolipid transporter activity | 3.94e-03 | 20 | 94 | 2 | GO:0046624 | |
| GeneOntologyMolecularFunction | antiporter activity | 4.12e-03 | 138 | 94 | 4 | GO:0015297 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 4.95e-03 | 73 | 94 | 3 | GO:0170055 | |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 5.20e-03 | 23 | 94 | 2 | GO:0015464 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 5.34e-03 | 75 | 94 | 3 | GO:0098960 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 5.75e-03 | 77 | 94 | 3 | GO:0005230 | |
| GeneOntologyMolecularFunction | solute:proton symporter activity | 6.13e-03 | 25 | 94 | 2 | GO:0015295 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 6.62e-03 | 26 | 94 | 2 | GO:0005248 | |
| GeneOntologyMolecularFunction | transaminase activity | 6.62e-03 | 26 | 94 | 2 | GO:0008483 | |
| GeneOntologyMolecularFunction | transferase activity, transferring nitrogenous groups | 7.65e-03 | 28 | 94 | 2 | GO:0016769 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 7.65e-03 | 28 | 94 | 2 | GO:0140326 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 8.20e-03 | 29 | 94 | 2 | GO:0005416 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 8.71e-03 | 171 | 94 | 4 | GO:0015081 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 9.33e-03 | 31 | 94 | 2 | GO:0099604 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 1.05e-02 | 33 | 94 | 2 | GO:0033764 | |
| GeneOntologyBiologicalProcess | sensory perception | LRAT OR4C3 CHRNA9 OR4A8 OR6S1 OR4Q2 OR4A5 OR10H2 TAS2R36 KCNJ10 SCN8A OR4M1 TRPM8 OR4K5 NMUR2 TAS2R30 TAS2R46 OR10X1 OR52A1 OR4K14 SLC52A3 RNF170 | 2.46e-09 | 1072 | 95 | 22 | GO:0007600 |
| GeneOntologyBiologicalProcess | organic anion transport | SLC32A1 SLC25A18 NF1 SLC7A13 SLC35D2 SLC16A14 KCNJ10 SLC22A10 SLCO1B3 SLC47A1 NMUR2 ARHGEF11 SLCO1B1 SLC16A12 SLC52A3 | 1.32e-08 | 515 | 95 | 15 | GO:0015711 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR4C3 OR4A8 OR6S1 OR4Q2 OR4A5 OR10H2 TAS2R36 OR4M1 OR4K5 TAS2R30 TAS2R46 OR10X1 OR52A1 OR4K14 | 4.70e-08 | 485 | 95 | 14 | GO:0050907 |
| GeneOntologyBiologicalProcess | carboxylic acid transport | SLC32A1 SLC25A18 NF1 SLC7A13 SLC35D2 SLC16A14 KCNJ10 SLCO1B3 SLC47A1 NMUR2 ARHGEF11 SLCO1B1 SLC16A12 | 4.99e-08 | 410 | 95 | 13 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | SLC32A1 SLC25A18 NF1 SLC7A13 SLC35D2 SLC16A14 KCNJ10 SLCO1B3 SLC47A1 NMUR2 ARHGEF11 SLCO1B1 SLC16A12 | 5.29e-08 | 412 | 95 | 13 | GO:0015849 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR4C3 CHRNA9 OR4A8 OR6S1 OR4Q2 OR4A5 OR10H2 TAS2R36 OR4M1 OR4K5 TAS2R30 TAS2R46 OR10X1 OR52A1 OR4K14 | 6.58e-08 | 582 | 95 | 15 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR4C3 OR4A8 OR6S1 OR4Q2 OR4A5 OR10H2 TAS2R36 OR4M1 OR4K5 TAS2R30 TAS2R46 OR10X1 OR52A1 OR4K14 | 1.22e-07 | 524 | 95 | 14 | GO:0009593 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR4C3 OR4A8 OR6S1 OR4Q2 OR4A5 OR10H2 TAS2R36 OR4M1 OR4K5 TAS2R30 TAS2R46 OR10X1 OR52A1 OR4K14 | 2.05e-07 | 547 | 95 | 14 | GO:0007606 |
| GeneOntologyBiologicalProcess | L-amino acid transport | 6.71e-07 | 108 | 95 | 7 | GO:0015807 | |
| GeneOntologyBiologicalProcess | detection of stimulus | OR4C3 CHRNA9 OR4A8 OR6S1 OR4Q2 OR4A5 OR10H2 TAS2R36 OR4M1 OR4K5 TAS2R30 TAS2R46 OR10X1 OR52A1 OR4K14 | 1.03e-06 | 722 | 95 | 15 | GO:0051606 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | TPRA1 OR4C3 GALR1 OR4A8 OR6S1 PLPPR4 OR4Q2 OR4A5 OR10H2 TAS2R36 NPSR1 OR4M1 OR4K5 NMUR2 TAS2R30 TAS2R46 ARHGEF11 CHRM5 OR10X1 OR52A1 OR4K14 | 1.13e-06 | 1395 | 95 | 21 | GO:0007186 |
| GeneOntologyBiologicalProcess | L-glutamate import | 2.20e-06 | 46 | 95 | 5 | GO:0051938 | |
| GeneOntologyBiologicalProcess | acidic amino acid transport | 2.48e-06 | 84 | 95 | 6 | GO:0015800 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR4C3 OR4A8 OR6S1 OR4Q2 OR4A5 OR10H2 OR4M1 OR4K5 OR10X1 OR52A1 OR4K14 | 4.82e-06 | 432 | 95 | 11 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR4C3 OR4A8 OR6S1 OR4Q2 OR4A5 OR10H2 OR4M1 OR4K5 OR10X1 OR52A1 OR4K14 | 9.66e-06 | 465 | 95 | 11 | GO:0007608 |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | 1.04e-05 | 163 | 95 | 7 | GO:1905039 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 1.22e-05 | 167 | 95 | 7 | GO:1903825 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 1.95e-05 | 120 | 95 | 6 | GO:0003333 | |
| GeneOntologyBiologicalProcess | L-glutamate transmembrane transport | 1.98e-05 | 35 | 95 | 4 | GO:0015813 | |
| GeneOntologyBiologicalProcess | amino acid transport | 3.32e-05 | 195 | 95 | 7 | GO:0006865 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC32A1 TRPM4 SLC25A18 CHRNA9 KCNJ10 SCN4A SLC22A10 NPSR1 SCN8A SLCO1B3 SLC47A1 TRPM8 NMUR2 NIPAL3 SLCO1B1 CHRND ATP6V0A2 SLC5A2 | 4.86e-05 | 1374 | 95 | 18 | GO:0006811 |
| GeneOntologyBiologicalProcess | locomotory behavior | 5.05e-05 | 284 | 95 | 8 | GO:0007626 | |
| GeneOntologyBiologicalProcess | L-alpha-amino acid transmembrane transport | 5.11e-05 | 87 | 95 | 5 | GO:1902475 | |
| GeneOntologyBiologicalProcess | behavior | APH1B TRPM4 SELENOP ABCA2 MYG1 NF1 CWH43 KCNJ10 NPSR1 SCN8A NMUR2 NIPAL3 SDK1 RNF170 | 5.60e-05 | 891 | 95 | 14 | GO:0007610 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC32A1 TRPM4 SLC25A18 CHRNA9 KCNJ10 SCN4A NPSR1 SCN8A SLC47A1 TRPM8 NMUR2 NIPAL3 ATP6V0A2 SLC5A2 XPR1 | 6.08e-05 | 1017 | 95 | 15 | GO:0098660 |
| GeneOntologyBiologicalProcess | retinol metabolic process | 1.04e-04 | 53 | 95 | 4 | GO:0042572 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC32A1 TRPM4 SLC25A18 CHRNA9 KCNJ10 SCN4A NPSR1 SCN8A SLC47A1 TRPM8 NMUR2 NIPAL3 CHRND ATP6V0A2 SLC5A2 | 1.69e-04 | 1115 | 95 | 15 | GO:0034220 |
| GeneOntologyBiologicalProcess | walking behavior | 1.69e-04 | 60 | 95 | 4 | GO:0090659 | |
| GeneOntologyBiologicalProcess | alkaloid catabolic process | 2.08e-04 | 5 | 95 | 2 | GO:0009822 | |
| GeneOntologyBiologicalProcess | dicarboxylic acid transport | 2.34e-04 | 120 | 95 | 5 | GO:0006835 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 2.43e-04 | 121 | 95 | 5 | GO:0051899 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC32A1 TRPM4 SLC25A18 CHRNA9 KCNJ10 SCN4A NPSR1 SCN8A SLC47A1 TRPM8 NIPAL3 ATP6V0A2 SLC5A2 | 3.06e-04 | 922 | 95 | 13 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoterpenoid metabolic process | 3.11e-04 | 6 | 95 | 2 | GO:0016098 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC32A1 TRPM4 SLC25A18 CHRNA9 KCNJ10 SCN4A NPSR1 SCN8A SLC47A1 TRPM8 NIPAL3 ATP6V0A2 SLC5A2 | 3.76e-04 | 942 | 95 | 13 | GO:0098655 |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 5.41e-04 | 144 | 95 | 5 | GO:0006720 | |
| GeneOntologyBiologicalProcess | lipid transport | 5.44e-04 | 506 | 95 | 9 | GO:0006869 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 6.05e-04 | 36 | 95 | 3 | GO:0086010 | |
| GeneOntologyBiologicalProcess | phospholipid metabolic process | 6.13e-04 | 410 | 95 | 8 | GO:0006644 | |
| GeneOntologyBiologicalProcess | alkaloid metabolic process | 7.40e-04 | 9 | 95 | 2 | GO:0009820 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 7.64e-04 | 89 | 95 | 4 | GO:0001523 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC32A1 TRPM4 SLC25A18 CHRNA9 KCNJ10 SCN4A NPSR1 SCN8A SLC47A1 TRPM8 NIPAL3 CHRND ATP6V0A2 SLC5A2 | 8.17e-04 | 1157 | 95 | 14 | GO:0006812 |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 9.38e-04 | 94 | 95 | 4 | GO:0016101 | |
| GeneOntologyBiologicalProcess | phospholipid dephosphorylation | 1.09e-03 | 44 | 95 | 3 | GO:0046839 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of bitter taste | 1.09e-03 | 44 | 95 | 3 | GO:0001580 | |
| GeneOntologyBiologicalProcess | pigment catabolic process | 1.12e-03 | 11 | 95 | 2 | GO:0046149 | |
| GeneOntologyBiologicalProcess | heme catabolic process | 1.12e-03 | 11 | 95 | 2 | GO:0042167 | |
| GeneOntologyBiologicalProcess | lipid localization | 1.18e-03 | 565 | 95 | 9 | GO:0010876 | |
| GeneOntologyCellularComponent | transporter complex | TRPM4 ABCA2 CATSPERE CHRNA9 KCNJ10 SCN4A SCN8A ATP10B CHRND ATP6V0A2 | 2.00e-04 | 550 | 95 | 10 | GO:1990351 |
| GeneOntologyCellularComponent | sodium channel complex | 3.05e-04 | 29 | 95 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | TRPM4 ABCA2 CATSPERE CHRNA9 KCNJ10 SCN4A SCN8A CHRND ATP6V0A2 | 6.26e-04 | 523 | 95 | 9 | GO:1902495 |
| GeneOntologyCellularComponent | basolateral plasma membrane | 6.45e-04 | 320 | 95 | 7 | GO:0016323 | |
| GeneOntologyCellularComponent | basal plasma membrane | 1.16e-03 | 354 | 95 | 7 | GO:0009925 | |
| GeneOntologyCellularComponent | basal part of cell | 1.69e-03 | 378 | 95 | 7 | GO:0045178 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.69e-03 | 378 | 95 | 7 | GO:0034702 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | APH1B LRAT SCAP CYP2D6 CYP3A4 JKAMP ALG8 UBAC2 TRPM8 ATP10B BFAR UBIAD1 MBOAT2 RNF170 | 2.07e-03 | 1293 | 95 | 14 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | APH1B LRAT SCAP CYP2D6 CYP3A4 JKAMP ALG8 UBAC2 TRPM8 ATP10B BFAR UBIAD1 MBOAT2 RNF170 | 2.16e-03 | 1299 | 95 | 14 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | APH1B LRAT SCAP CYP2D6 CYP3A4 JKAMP ALG8 UBAC2 TRPM8 ATP10B BFAR UBIAD1 MBOAT2 RNF170 | 2.62e-03 | 1327 | 95 | 14 | GO:0042175 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 2.66e-03 | 17 | 95 | 2 | GO:0001518 | |
| GeneOntologyCellularComponent | acetylcholine-gated channel complex | 2.98e-03 | 18 | 95 | 2 | GO:0005892 | |
| HumanPheno | Bilirubinuria | 2.13e-05 | 2 | 24 | 2 | HP:0031811 | |
| Domain | GPCR_Rhodpsn_7TM | OR4C3 GALR1 OR6S1 OR4A5 OR10H2 NPSR1 OR4M1 OR4K5 NMUR2 CHRM5 OR10X1 OR52A1 OR4K14 | 1.88e-05 | 670 | 90 | 13 | IPR017452 |
| Domain | 7tm_1 | OR4C3 GALR1 OR6S1 OR4A5 OR10H2 NPSR1 OR4M1 OR4K5 NMUR2 CHRM5 OR10X1 OR52A1 OR4K14 | 2.09e-05 | 677 | 90 | 13 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR4C3 GALR1 OR6S1 OR4A5 OR10H2 NPSR1 OR4M1 OR4K5 NMUR2 CHRM5 OR10X1 OR52A1 OR4K14 | 2.37e-05 | 685 | 90 | 13 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR4C3 GALR1 OR6S1 OR4A5 OR10H2 NPSR1 OR4M1 OR4K5 NMUR2 CHRM5 OR10X1 OR52A1 OR4K14 | 2.59e-05 | 691 | 90 | 13 | PS50262 |
| Domain | GPCR_Rhodpsn | OR4C3 GALR1 OR6S1 OR4A5 OR10H2 NPSR1 OR4M1 OR4K5 NMUR2 CHRM5 OR10X1 OR52A1 OR4K14 | 2.63e-05 | 692 | 90 | 13 | IPR000276 |
| Domain | MFS_dom | 4.63e-05 | 134 | 90 | 6 | IPR020846 | |
| Domain | Olfact_rcpt | 1.16e-04 | 393 | 90 | 9 | IPR000725 | |
| Domain | MFS | 1.75e-04 | 108 | 90 | 5 | PS50850 | |
| Domain | Na_channel_asu | 1.01e-03 | 10 | 90 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 1.01e-03 | 10 | 90 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 1.01e-03 | 10 | 90 | 2 | PF06512 | |
| Domain | ABC_A | 1.47e-03 | 12 | 90 | 2 | IPR026082 | |
| Domain | OA_transporter | 1.47e-03 | 12 | 90 | 2 | IPR004156 | |
| Domain | OATP | 1.47e-03 | 12 | 90 | 2 | PF03137 | |
| Domain | Ion_trans_dom | 2.25e-03 | 114 | 90 | 4 | IPR005821 | |
| Domain | Ion_trans | 2.25e-03 | 114 | 90 | 4 | PF00520 | |
| Domain | Nicotinic_acetylcholine_rcpt | 2.64e-03 | 16 | 90 | 2 | IPR002394 | |
| Domain | - | 3.34e-03 | 18 | 90 | 2 | 1.20.144.10 | |
| Domain | acidPPc | 3.34e-03 | 18 | 90 | 2 | SM00014 | |
| Domain | P_Acid_Pase_2/haloperoxidase | 4.12e-03 | 20 | 90 | 2 | IPR000326 | |
| Domain | PAP2 | 4.12e-03 | 20 | 90 | 2 | PF01569 | |
| Domain | - | 5.44e-03 | 23 | 90 | 2 | 1.20.120.370 | |
| Domain | Acetylcholine_rcpt_TM | 5.44e-03 | 23 | 90 | 2 | IPR027361 | |
| Domain | MFS_1 | 6.12e-03 | 77 | 90 | 3 | PF07690 | |
| Domain | MFS | 6.12e-03 | 77 | 90 | 3 | IPR011701 | |
| Domain | TAS2R | 6.92e-03 | 26 | 90 | 2 | PF05296 | |
| Domain | T2R | 6.92e-03 | 26 | 90 | 2 | IPR007960 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | LRAT TRPM4 OR4C3 CHRNA9 OR4A8 OR6S1 OR4Q2 OR4A5 OR10H2 HSD17B6 OR4M1 OR4K5 TAS2R30 TAS2R46 EPB41L3 OR10X1 OR52A1 OR4K14 | 2.00e-09 | 636 | 72 | 18 | M41834 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC32A1 TRPM4 ABCA2 SLC25A18 SLC35D2 SLCO1B3 SLC47A1 TRPM8 ATP10B NIPAL3 SLCO1B1 ABCA8 ATP6V0A2 SLC5A2 | 7.29e-06 | 681 | 72 | 14 | MM14985 |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR4C3 OR4A8 OR6S1 OR4Q2 OR4A5 OR10H2 OR4M1 OR4K5 OR10X1 OR52A1 OR4K14 | 7.93e-06 | 417 | 72 | 11 | M4072 |
| Pathway | REACTOME_ATORVASTATIN_ADME | 1.05e-05 | 9 | 72 | 3 | M45020 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC32A1 TRPM4 ABCA2 SLC25A18 SLC35D2 SLCO1B3 SLC47A1 TRPM8 ATP10B NIPAL3 SLCO1B1 ABCA8 ATP6V0A2 SLC5A2 | 1.76e-05 | 736 | 72 | 14 | M27287 |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 4.47e-05 | 14 | 72 | 3 | M39328 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 5.56e-05 | 15 | 72 | 3 | MM15697 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | 1.55e-04 | 389 | 72 | 9 | M14091 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 2.07e-04 | 238 | 72 | 7 | MM15076 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 2.73e-04 | 249 | 72 | 7 | M5988 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESIN_LIKE_SPMS | 3.81e-04 | 6 | 72 | 2 | M27909 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 4.14e-04 | 190 | 72 | 6 | MM15687 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESINS | 7.06e-04 | 8 | 72 | 2 | M27891 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 1.18e-03 | 41 | 72 | 3 | MM15075 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 1.36e-03 | 43 | 72 | 3 | M881 | |
| Pathway | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | 1.37e-03 | 11 | 72 | 2 | M930 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 1.52e-03 | 430 | 72 | 8 | MM15160 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 1.64e-03 | 12 | 72 | 2 | M39611 | |
| Pathway | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | 1.64e-03 | 12 | 72 | 2 | MM15476 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESINS | 1.64e-03 | 12 | 72 | 2 | MM15616 | |
| Pathway | WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS | 1.64e-03 | 12 | 72 | 2 | M48096 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 1.76e-03 | 47 | 72 | 3 | M42524 | |
| Pathway | WP_SULFATASE_AND_AROMATASE_PATHWAY | 2.25e-03 | 14 | 72 | 2 | M48085 | |
| Pathway | REACTOME_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS | 2.25e-03 | 14 | 72 | 2 | M27331 | |
| Pathway | REACTOME_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS | 2.25e-03 | 14 | 72 | 2 | MM15062 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 2.25e-03 | 14 | 72 | 2 | M757 | |
| Pathway | REACTOME_DRUG_ADME | 2.32e-03 | 109 | 72 | 4 | M45012 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 2.42e-03 | 463 | 72 | 8 | M507 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 2.59e-03 | 15 | 72 | 2 | MM14704 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 2.59e-03 | 15 | 72 | 2 | M39717 | |
| Pathway | REACTOME_HEME_DEGRADATION | 2.59e-03 | 15 | 72 | 2 | M27060 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 2.64e-03 | 367 | 72 | 7 | M48346 | |
| Pubmed | The SLCO1B1*5 genetic variant is associated with statin-induced side effects. | 2.03e-07 | 5 | 96 | 3 | 19833260 | |
| Pubmed | 2.55e-07 | 20 | 96 | 4 | 21072184 | ||
| Pubmed | OR4C3 OR4A8 OR6S1 OR4Q2 OR4A5 OR10H2 OR4M1 OR4K5 OR10X1 OR52A1 OR4K14 | 3.12e-07 | 541 | 96 | 11 | 14983052 | |
| Pubmed | Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity. | 4.05e-07 | 6 | 96 | 3 | 20212519 | |
| Pubmed | 1.62e-06 | 31 | 96 | 4 | 20031551 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 18314419 | ||
| Pubmed | OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation. | 7.54e-06 | 2 | 96 | 2 | 21691816 | |
| Pubmed | Pharmacogenomics of oxycodone: a narrative literature review. | 7.54e-06 | 2 | 96 | 2 | 33728947 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 24361808 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 34481255 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 28063966 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 18433425 | ||
| Pubmed | Effect of cyp2d6*10 allele on the pharmacokinetics of loratadine in chinese subjects. | 7.54e-06 | 2 | 96 | 2 | 15932952 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 22240838 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 25701109 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 29944058 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 20007670 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 17412826 | ||
| Pubmed | SLCO1B1 and SLCO1B3 genetic mutations in Taiwanese patients with Rotor syndrome. | 7.54e-06 | 2 | 96 | 2 | 36964102 | |
| Pubmed | Contribution of OATP1B1 and OATP1B3 to the disposition of sorafenib and sorafenib-glucuronide. | 7.54e-06 | 2 | 96 | 2 | 23340295 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 33012655 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 29777022 | ||
| Pubmed | Down-regulation of OATP1B proteins correlates with hyperbilirubinemia in advanced cholestasis. | 7.54e-06 | 2 | 96 | 2 | 26191226 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 21433154 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 25868121 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 22771883 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 24194513 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 18180273 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 23436703 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 30862625 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 37723174 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 16633141 | ||
| Pubmed | Interaction of buprenorphine and its metabolite norbuprenorphine with cytochromes p450 in vitro. | 7.54e-06 | 2 | 96 | 2 | 12756210 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 24855184 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 15770075 | ||
| Pubmed | Probabilistic prediction of the human CYP3A4 and CYP2D6 metabolism sites. | 7.54e-06 | 2 | 96 | 2 | 19937844 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 26474710 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 25578040 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 23670789 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 24989890 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 23277250 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 17496208 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 23236639 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 27098745 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 24740327 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 21719246 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 20877131 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 24107805 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 24510399 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 30658716 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 16534140 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 31299240 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 38199567 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 15820320 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 23886114 | ||
| Pubmed | OATP1B1/1B3 activity in plated primary human hepatocytes over time in culture. | 7.54e-06 | 2 | 96 | 2 | 21787759 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 19797609 | ||
| Pubmed | Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3. | 7.54e-06 | 2 | 96 | 2 | 18321482 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 26376857 | ||
| Pubmed | 1.65e-05 | 193 | 96 | 6 | 19343046 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 31047942 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 28482130 | ||
| Pubmed | Assessment of the stereoselective metabolism of methaqualone in man by capillary electrophoresis. | 2.26e-05 | 3 | 96 | 2 | 12900872 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 26146841 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 34058179 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 32485484 | ||
| Pubmed | SLCO1B1, SLCO2B1, and SLCO1B3 polymorphisms and susceptibility to bladder cancer risk. | 2.26e-05 | 3 | 96 | 2 | 24762081 | |
| Pubmed | [CYP2D6, CYP3A5, and CYP3A4 gene polymorphism in Russian, Tatar, and Bashkir populations]. | 2.26e-05 | 3 | 96 | 2 | 25857198 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 18296417 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 34480108 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 30955241 | ||
| Pubmed | Effects of tuberculosis, race, and human gene SLCO1B1 polymorphisms on rifampin concentrations. | 2.26e-05 | 3 | 96 | 2 | 20660695 | |
| Pubmed | Influence of drug formulation on OATP1B-mediated transport of paclitaxel. | 2.26e-05 | 3 | 96 | 2 | 24755470 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 26316040 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 20350136 | ||
| Pubmed | OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity. | 2.26e-05 | 3 | 96 | 2 | 29337310 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 22136368 | ||
| Pubmed | Expression of Oatp2 in the Brain and Liver of Alzheimer Disease Mouse Model. | 2.26e-05 | 3 | 96 | 2 | 31967785 | |
| Pubmed | Genetic polymorphisms of cytochrome P450 among patients with Balkan endemic nephropathy (BEN). | 2.26e-05 | 3 | 96 | 2 | 15708542 | |
| Pubmed | Mutation screening in a Norwegian cohort with pheochromocytoma. | 2.26e-05 | 3 | 96 | 2 | 23407919 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 28013215 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 19890249 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 20051929 | ||
| Pubmed | Impact of regulatory polymorphisms in organic anion transporter genes in the human liver. | 2.26e-05 | 3 | 96 | 2 | 19620935 | |
| Pubmed | Urinary metabolites to assess in vivo ontogeny of hepatic drug metabolism in early neonatal life. | 2.26e-05 | 3 | 96 | 2 | 17609736 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 29422623 | ||
| Pubmed | Human OATP1B1, OATP1B3 and OATP1A2 can mediate the in vivo uptake and clearance of docetaxel. | 2.26e-05 | 3 | 96 | 2 | 24825069 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 21605066 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 22695893 | ||
| Pubmed | Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro. | 2.26e-05 | 3 | 96 | 2 | 12756206 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 19321127 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 18492796 | ||
| Pubmed | Differential Expression of OATP1B3 Mediates Unconjugated Testosterone Influx. | 2.26e-05 | 3 | 96 | 2 | 28389619 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 15327587 | ||
| Pubmed | Organic anion transporting polypeptide (OATP)-mediated transport of coproporphyrins I and III. | 2.26e-05 | 3 | 96 | 2 | 26383540 | |
| Pubmed | Organic anion transporting polypeptide 1B transporters modulate hydroxyurea pharmacokinetics. | 2.26e-05 | 3 | 96 | 2 | 23986199 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 18413659 | ||
| Pubmed | Genetic variability of CYP2D6, CYP3A4 and CYP3A5 among the Egyptian population. | 2.26e-05 | 3 | 96 | 2 | 33789449 | |
| Pubmed | Effect of genetic variations on ticagrelor plasma levels and clinical outcomes. | 2.26e-05 | 3 | 96 | 2 | 25935875 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 22203093 | ||
| Interaction | ENTREP3 interactions | 3.08e-08 | 120 | 82 | 8 | int:ENTREP3 | |
| Interaction | HTR3A interactions | 2.85e-07 | 108 | 82 | 7 | int:HTR3A | |
| Interaction | ST7L interactions | 5.80e-07 | 40 | 82 | 5 | int:ST7L | |
| Interaction | TMEM39A interactions | 1.63e-06 | 49 | 82 | 5 | int:TMEM39A | |
| Interaction | SLC12A9 interactions | 2.43e-06 | 53 | 82 | 5 | int:SLC12A9 | |
| Interaction | DNAJC18 interactions | 1.36e-05 | 75 | 82 | 5 | int:DNAJC18 | |
| Interaction | ST7 interactions | 1.63e-05 | 362 | 82 | 9 | int:ST7 | |
| Interaction | TRPM8 interactions | 5.07e-05 | 18 | 82 | 3 | int:TRPM8 | |
| Interaction | TM2D2 interactions | 8.19e-05 | 21 | 82 | 3 | int:TM2D2 | |
| Interaction | TYW1 interactions | 8.27e-05 | 109 | 82 | 5 | int:TYW1 | |
| Interaction | FZD2 interactions | 1.04e-04 | 60 | 82 | 4 | int:FZD2 | |
| Interaction | PCNX3 interactions | 1.80e-04 | 69 | 82 | 4 | int:PCNX3 | |
| Interaction | OR10H2 interactions | 2.12e-04 | 72 | 82 | 4 | int:OR10H2 | |
| Interaction | TTYH1 interactions | 2.21e-04 | 300 | 82 | 7 | int:TTYH1 | |
| Cytoband | 14q11.2 | 3.82e-05 | 180 | 95 | 5 | 14q11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12p12 | 9.32e-05 | 113 | 95 | 4 | chr12p12 | |
| Cytoband | 12q13 | 4.43e-04 | 71 | 95 | 3 | 12q13 | |
| Cytoband | 1p13 | 5.65e-04 | 17 | 95 | 2 | 1p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q11 | 6.53e-04 | 332 | 95 | 5 | chr14q11 | |
| GeneFamily | Solute carriers | SLC32A1 SLC25A18 SLC7A13 SLC35D2 SLC16A14 SLC22A10 SLC15A5 SLCO1B3 SLC47A1 SLCO1B1 SLC16A12 SLC5A2 SLC52A3 | 7.89e-09 | 395 | 75 | 13 | 752 |
| GeneFamily | Olfactory receptors, family 4 | 1.06e-06 | 129 | 75 | 7 | 151 | |
| GeneFamily | Phospholipid phosphatase related | 1.68e-04 | 5 | 75 | 2 | 1127 | |
| GeneFamily | Taste 2 receptors | 5.63e-04 | 39 | 75 | 3 | 1162 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 6.00e-04 | 9 | 75 | 2 | 1203 | |
| GeneFamily | ATP binding cassette subfamily A | 1.50e-03 | 14 | 75 | 2 | 805 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 1.96e-03 | 16 | 75 | 2 | 173 | |
| GeneFamily | Transient receptor potential cation channels | 5.99e-03 | 28 | 75 | 2 | 249 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_top-relative-expression-ranked_500 | SELENOP CWH43 CYP2D6 SLC7A13 C6orf89 SLC16A14 KCNJ10 SLC47A1 SLC5A2 | 2.15e-05 | 400 | 81 | 9 | gudmap_kidney_adult_JuxtaGlom_Ren1_500 |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-07 | 183 | 94 | 7 | 5472cdce6d99314d229418412acf1fff6340db7d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-07 | 183 | 94 | 7 | 93213124e55d1b673dd345188caf8b5bd31d99fe | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-07 | 184 | 94 | 7 | f6d6b3ddada66dae28d3306415bf4efe0934208a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-07 | 184 | 94 | 7 | 5939527d24d299e562e707469c9123890edd76be | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-07 | 186 | 94 | 7 | d57c40b3fe5cfc87e771df76533d9a3e94678b04 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.69e-06 | 185 | 94 | 6 | 1d731d69d8db8aef4a11439b8abd1030c7e6ac4c | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.69e-06 | 185 | 94 | 6 | b8d02c9426740ffcb69d2e6f95473b388149d297 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.77e-06 | 186 | 94 | 6 | 90eaf6ffb4ce0c34fa1e79f0c8f36f217f44973b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.77e-06 | 186 | 94 | 6 | bd8a9753df219084e19e7f94447856e86608325c | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.86e-06 | 187 | 94 | 6 | f0de86ef25e344d9b1860ee26308877d6c25ed31 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.86e-06 | 187 | 94 | 6 | b71d0cd91bc98e020757c1d071a13ad48d718bcf | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.95e-06 | 188 | 94 | 6 | 14072d0b82df55711d5356b2209f4f0bdd90dc27 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.95e-06 | 188 | 94 | 6 | b04fd6a724c117eb9a979c29b91f90113feb7a5c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.04e-06 | 189 | 94 | 6 | 70eea8c94fa56bb15bee8065de47acea156794e9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.04e-06 | 189 | 94 | 6 | 784ace2be87f2ecb19490f4974f63a559516e0eb | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.04e-06 | 189 | 94 | 6 | b60c8a29d3169c4830fe63b01db90c57660fc239 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.13e-06 | 190 | 94 | 6 | 07f21386ea6eb23416a537d2250e3042efe93fb0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.13e-06 | 190 | 94 | 6 | 6b101359f397020a21e2bfd15851cb48e71f4502 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.13e-06 | 190 | 94 | 6 | 396b7225c2430db3dc55a3d0db70239b71987229 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 160 | 94 | 5 | 0544bc465af208da448858d6e174ff56f2e08a46 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 160 | 94 | 5 | 8a7a73b0ee1877fe02d47f745d36ae2858b529e1 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 171 | 94 | 5 | 48fc4eca18b102b5ec5050f758281292ee8e10c6 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 171 | 94 | 5 | 05fcc72df50a380a913821b5781d9621df37d328 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.58e-05 | 176 | 94 | 5 | 581045e61cdcdfa85701343d1a7c0a72a36606a7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.43e-05 | 184 | 94 | 5 | a2191dd5546efd357b23e625beb3c5820476f243 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.78e-05 | 187 | 94 | 5 | 97e520705491c8f52a32025311a9fa7b9176979a | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.91e-05 | 188 | 94 | 5 | 60242c29c7f16c94a84685d3bc4ed93a66e70152 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.91e-05 | 188 | 94 | 5 | d9692b6048d9b85524a07a1807bdd4757731c151 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.91e-05 | 188 | 94 | 5 | 505b6b4277d7dea87aee27191d0acca67928b8e6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.03e-05 | 189 | 94 | 5 | 37ecbd73408d462b47d7e5611f203143e08a2689 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.16e-05 | 190 | 94 | 5 | 2de8e4cfeee350a9a76af749d6ce58d948c129b8 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.16e-05 | 190 | 94 | 5 | ae97df1b06bcd46c05759b53c35dc8fea97f4ac1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-05 | 191 | 94 | 5 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-05 | 191 | 94 | 5 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.29e-05 | 191 | 94 | 5 | 2110a1dd10730ad7ee7a265fb1716ab3ddafcf4a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.29e-05 | 191 | 94 | 5 | 2b056cbe2e82e056e1f798974999378460eb1d16 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.29e-05 | 191 | 94 | 5 | a90c8ab2077e52bbc998457c85a1b9867f9c8c93 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.42e-05 | 192 | 94 | 5 | 8dc3016601148243196e925641c9507e9d58c9e0 | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-TRAM-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 5.83e-05 | 195 | 94 | 5 | dabf667875ed48fdce4f803f5ead39c71a6df42b | |
| ToppCell | Macroglial|World / cells hierarchy compared to all cells using T-Statistic | 6.58e-05 | 200 | 94 | 5 | e6935ad49216d2500c15c05cbc2b89402c65e838 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.58e-05 | 200 | 94 | 5 | acdef0b9096c774040948fc75621ff2b08ea2ee8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.58e-05 | 200 | 94 | 5 | 091a18d6efed81cab99955c3047f172170f70476 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.58e-05 | 200 | 94 | 5 | 3b8513defe25262ab4b492345b2628570eaefd17 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.58e-05 | 200 | 94 | 5 | 829978708463a7459fe1041bd90196775bc4b531 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-Neutrophil|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.47e-04 | 126 | 94 | 4 | ec32bfd6cd93fbe02f7577893c82b04d209a52e7 | |
| Drug | Proguanil | 6.56e-07 | 5 | 93 | 3 | ctd:D002727 | |
| Drug | probenecid | 7.29e-07 | 123 | 93 | 7 | CID000004911 | |
| Drug | ipratropium bromide | 1.22e-06 | 46 | 93 | 5 | CID000003746 | |
| Drug | nateglinide | 2.28e-06 | 7 | 93 | 3 | ctd:C060142 | |
| Drug | quindine | 3.26e-06 | 219 | 93 | 8 | CID000001065 | |
| Drug | Fusidic Acid | 3.64e-06 | 8 | 93 | 3 | ctd:D005672 | |
| Drug | cimetidine | 8.85e-06 | 179 | 93 | 7 | CID000002756 | |
| Drug | repaglinide | 1.06e-05 | 11 | 93 | 3 | ctd:C072379 | |
| Drug | Ondansetron | 1.41e-05 | 12 | 93 | 3 | ctd:D017294 | |
| Drug | glimepiride | 1.41e-05 | 12 | 93 | 3 | ctd:C057619 | |
| Drug | norlevorphanol | 1.65e-05 | 2 | 93 | 2 | ctd:C054116 | |
| Drug | norbuprenorphine | 1.65e-05 | 2 | 93 | 2 | ctd:C043585 | |
| Drug | (5-(3-(4-(2-bromo-5-fluorophenoxy)piperidin-1-yl)isoxazol-5-yl)-2H-tetrazol-2-yl)acetic acid | 1.65e-05 | 2 | 93 | 2 | ctd:C561635 | |
| Drug | Pyrantel | 1.65e-05 | 2 | 93 | 2 | ctd:D011715 | |
| Drug | desethylchloroquine | 1.65e-05 | 2 | 93 | 2 | ctd:C007278 | |
| Drug | YM 758 | 1.65e-05 | 2 | 93 | 2 | ctd:C530155 | |
| Drug | N,O-didesmethylvenlafaxine | 1.65e-05 | 2 | 93 | 2 | ctd:C434333 | |
| Drug | AC1Q7BBT | 2.32e-05 | 14 | 93 | 3 | CID000086545 | |
| Drug | sulfinpyrazone | 2.89e-05 | 87 | 93 | 5 | CID000005342 | |
| Drug | isoamyl alcohol | 4.42e-05 | 48 | 93 | 4 | CID000031260 | |
| Drug | 3-methoxymorphinan | 4.94e-05 | 3 | 93 | 2 | ctd:C028657 | |
| Drug | N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine | 4.94e-05 | 3 | 93 | 2 | ctd:C051570 | |
| Drug | indomethacin phenethylamide | 4.94e-05 | 3 | 93 | 2 | ctd:C489645 | |
| Drug | Verapamil | 7.14e-05 | 105 | 93 | 5 | ctd:D014700 | |
| Drug | orphenadrine | 8.14e-05 | 56 | 93 | 4 | CID000004601 | |
| Drug | Glyburide | 9.35e-05 | 58 | 93 | 4 | ctd:D005905 | |
| Drug | Clarithromycin | 9.60e-05 | 22 | 93 | 3 | ctd:D017291 | |
| Drug | estradiol-17 beta-glucuronide | 9.60e-05 | 22 | 93 | 3 | ctd:C025483 | |
| Drug | CI-1034 | 9.60e-05 | 22 | 93 | 3 | CID000157574 | |
| Drug | Quinine | 9.60e-05 | 22 | 93 | 3 | ctd:D011803 | |
| Drug | 1-(6-((2-(dimethylamino)ethyl)(methyl)amino)-1,3-dimethyl-1H-pyrazolo(3,4-b)pyridine-5-carbonyl)-3-(3-isopropoxyphenyl)urea | 9.85e-05 | 4 | 93 | 2 | ctd:C558737 | |
| Drug | fenproporex | 9.85e-05 | 4 | 93 | 2 | ctd:C026013 | |
| Drug | oxatomide | 9.85e-05 | 4 | 93 | 2 | ctd:C015408 | |
| Drug | 7-methoxy-N-((6-(3-methylisothiazol-5-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-yl)methyl)-1,5-naphthyridin-4-amine | 9.85e-05 | 4 | 93 | 2 | ctd:C556297 | |
| Drug | 1-(2-methyl-4-methoxyphenyl)-4-((2-hydroxyethyl)amino)-6-trifluoromethoxy-2,3-dihydropyrrolo(3,2-c)quinoline | 9.85e-05 | 4 | 93 | 2 | ctd:C439392 | |
| Drug | rabeprazole-thioether | 9.85e-05 | 4 | 93 | 2 | ctd:C523099 | |
| Drug | Dihydromicrocystin Lr | 9.85e-05 | 4 | 93 | 2 | CID006441227 | |
| Drug | rifamycin SV | 9.85e-05 | 4 | 93 | 2 | ctd:C023808 | |
| Drug | microcystin-LF | 9.85e-05 | 4 | 93 | 2 | ctd:C524165 | |
| Drug | 17-AAG; Up 200; 1uM; HL60; HT_HG-U133A | 1.06e-04 | 183 | 93 | 6 | 6166_UP | |
| Drug | estrone sulfate | 1.10e-04 | 23 | 93 | 3 | ctd:C017296 | |
| Drug | procyclidine | 1.25e-04 | 24 | 93 | 3 | CID000004919 | |
| Drug | bisphenol F | 1.25e-04 | 24 | 93 | 3 | ctd:C000611646 | |
| Drug | 11-cis-retinal | 1.27e-04 | 189 | 93 | 6 | CID000001070 | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 1.27e-04 | 189 | 93 | 6 | 4430_UP | |
| Drug | Tramadol | 1.42e-04 | 25 | 93 | 3 | ctd:D014147 | |
| Drug | lamotrigine | 1.42e-04 | 25 | 93 | 3 | ctd:C047781 | |
| Drug | Ticlopidine | 1.42e-04 | 25 | 93 | 3 | ctd:D013988 | |
| Drug | disopyramide | 1.55e-04 | 66 | 93 | 4 | CID000003114 | |
| Drug | Meglumine [6284-40-8]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 1.59e-04 | 197 | 93 | 6 | 6445_UP | |
| Drug | Pantothenic acid calcium salt monohydrate [63409-48-3]; Down 200; 8uM; HL60; HT_HG-U133A | 1.59e-04 | 197 | 93 | 6 | 1311_DN | |
| Drug | Heliotrine [303-33-3]; Down 200; 12.8uM; HL60; HT_HG-U133A | 1.59e-04 | 197 | 93 | 6 | 2180_DN | |
| Drug | dimethocaine | 1.64e-04 | 5 | 93 | 2 | ctd:C066888 | |
| Drug | natisedine | 1.64e-04 | 5 | 93 | 2 | CID000064644 | |
| Drug | L-754,394 | 1.64e-04 | 5 | 93 | 2 | CID005481990 | |
| Drug | hyodeoxycholic acid | 1.64e-04 | 5 | 93 | 2 | ctd:C010471 | |
| Drug | lephetamine | 1.64e-04 | 5 | 93 | 2 | ctd:C011896 | |
| Drug | eupatorin | 1.64e-04 | 5 | 93 | 2 | ctd:C103110 | |
| Drug | 4-ipomeanol | 1.64e-04 | 5 | 93 | 2 | ctd:C001470 | |
| Drug | 2Cmp | 1.64e-04 | 5 | 93 | 2 | CID000023392 | |
| Drug | 2,2',4,4',5,6'-hexabromodiphenyl ether | 1.64e-04 | 5 | 93 | 2 | ctd:C555859 | |
| Drug | N-ethyl-1,2-diphenylethylamine | 1.64e-04 | 5 | 93 | 2 | ctd:C000598690 | |
| Drug | fenproporex | 1.64e-04 | 5 | 93 | 2 | CID000061810 | |
| Drug | verapamil | ABCA2 CHRNA9 CYP3A4 KCNJ10 HSD17B6 SCN4A SLCO1B1 ABCA8 CHRND | 1.79e-04 | 490 | 93 | 9 | CID000002520 |
| Drug | tariquidar | 1.80e-04 | 27 | 93 | 3 | CID000148201 | |
| Drug | Digocin | 1.95e-04 | 70 | 93 | 4 | CID000003062 | |
| Drug | encainide | 2.01e-04 | 28 | 93 | 3 | CID000048040 | |
| Drug | NSC221991 | 2.17e-04 | 72 | 93 | 4 | CID000004580 | |
| Drug | Dehydroepiandrosterone Sulfate | 2.23e-04 | 29 | 93 | 3 | ctd:D019314 | |
| Drug | fexofenadine | 2.29e-04 | 73 | 93 | 4 | CID000003348 | |
| Drug | NSC100058 | 2.41e-04 | 74 | 93 | 4 | CID000003449 | |
| Drug | eserine hemisulfate | 2.41e-04 | 74 | 93 | 4 | CID000004811 | |
| Drug | menatetrenone | 2.45e-04 | 6 | 93 | 2 | ctd:C030814 | |
| Drug | 2,2-(2-chlorophenyl-4'-chlorophenyl)acetic acid | 2.45e-04 | 6 | 93 | 2 | ctd:C054917 | |
| Drug | trospium chloride | 2.45e-04 | 6 | 93 | 2 | ctd:C003330 | |
| Drug | N-desmethyltamoxifen | 2.45e-04 | 6 | 93 | 2 | ctd:C028787 | |
| Drug | 8-Methylxanthine | 2.45e-04 | 6 | 93 | 2 | CID000087061 | |
| Drug | APETx1, Anthopleura elegantissima | 2.45e-04 | 6 | 93 | 2 | ctd:C475726 | |
| Drug | prednisolone phosphate | 2.45e-04 | 6 | 93 | 2 | CID000004896 | |
| Drug | 5-methoxyindole | 2.45e-04 | 6 | 93 | 2 | ctd:C487413 | |
| Drug | Cyclodextrins | 2.45e-04 | 6 | 93 | 2 | ctd:D003505 | |
| Drug | mepirodipine | 2.45e-04 | 6 | 93 | 2 | ctd:C050699 | |
| Drug | S-(chloro-1,2,2-trifluoroethyl)-L-cysteine | 2.45e-04 | 6 | 93 | 2 | CID000107692 | |
| Drug | milnacipran | 2.47e-04 | 30 | 93 | 3 | CID000055480 | |
| Drug | diphenhydramine | 2.54e-04 | 75 | 93 | 4 | CID000003100 | |
| Drug | tropicamide | 3.00e-04 | 32 | 93 | 3 | CID000005593 | |
| Drug | amiloride | 3.11e-04 | 315 | 93 | 7 | CID000016230 | |
| Drug | decamethrin | 3.34e-04 | 146 | 93 | 5 | ctd:C017180 | |
| Drug | bupropion | 3.41e-04 | 81 | 93 | 4 | CID000000444 | |
| Drug | 5-n-butyl-pyrazolo(1,5-a)pyrimidine | 3.42e-04 | 7 | 93 | 2 | ctd:C547858 | |
| Drug | retinyl stearate | 3.42e-04 | 7 | 93 | 2 | CID006438398 | |
| Drug | Dextrorphan | 3.42e-04 | 7 | 93 | 2 | ctd:D003917 | |
| Drug | 16-O-demethylaconitine | 3.42e-04 | 7 | 93 | 2 | ctd:C486136 | |
| Drug | demethylphalloin | 3.42e-04 | 7 | 93 | 2 | CID000114793 | |
| Drug | telithromycin | 3.42e-04 | 7 | 93 | 2 | ctd:C106791 | |
| Drug | 5-hydroxydiclofenac | 3.42e-04 | 7 | 93 | 2 | ctd:C117715 | |
| Drug | norfluoxetine | 3.42e-04 | 7 | 93 | 2 | ctd:C036139 | |
| Drug | quinidine-N-oxide | 3.42e-04 | 7 | 93 | 2 | CID000050979 | |
| Drug | 12-hydroxyellipticine | 3.42e-04 | 7 | 93 | 2 | ctd:C517214 | |
| Drug | E-10 | 3.60e-04 | 34 | 93 | 3 | CID006452259 | |
| Disease | Rotor syndrome | 9.00e-06 | 2 | 89 | 2 | cv:C0220991 | |
| Disease | HYPERBILIRUBINEMIA, ROTOR TYPE, DIGENIC | 9.00e-06 | 2 | 89 | 2 | C4016905 | |
| Disease | HYPERBILIRUBINEMIA, ROTOR TYPE | 9.00e-06 | 2 | 89 | 2 | 237450 | |
| Disease | Rotor Syndrome | 9.00e-06 | 2 | 89 | 2 | C0220991 | |
| Disease | Ondansetron response | 2.69e-05 | 3 | 89 | 2 | cv:CN417142 | |
| Disease | estrone conjugate measurement | 5.38e-05 | 4 | 89 | 2 | EFO_0007971 | |
| Disease | Clozapine response | 5.38e-05 | 4 | 89 | 2 | cv:CN077971 | |
| Disease | bilirubin metabolic disorder (implicated_via_orthology) | 8.94e-05 | 5 | 89 | 2 | DOID:2741 (implicated_via_orthology) | |
| Disease | bilirubin metabolic disorder (is_implicated_in) | 1.34e-04 | 6 | 89 | 2 | DOID:2741 (is_implicated_in) | |
| Disease | deoxycholic acid glucuronide measurement | 2.49e-04 | 8 | 89 | 2 | EFO_0800575 | |
| Disease | Tremor, Neonatal | 3.19e-04 | 9 | 89 | 2 | C0235843 | |
| Disease | Action Tremor | 3.19e-04 | 9 | 89 | 2 | C0234376 | |
| Disease | Passive Tremor | 3.19e-04 | 9 | 89 | 2 | C0234377 | |
| Disease | Static Tremor | 3.19e-04 | 9 | 89 | 2 | C0234378 | |
| Disease | Resting Tremor | 3.19e-04 | 9 | 89 | 2 | C0234379 | |
| Disease | Intermittent Tremor | 3.19e-04 | 9 | 89 | 2 | C0234372 | |
| Disease | Fine Tremor | 3.19e-04 | 9 | 89 | 2 | C0234373 | |
| Disease | Coarse Tremor | 3.19e-04 | 9 | 89 | 2 | C0234374 | |
| Disease | Massive Tremor | 3.19e-04 | 9 | 89 | 2 | C0234375 | |
| Disease | Persistent Tremor | 3.19e-04 | 9 | 89 | 2 | C0234370 | |
| Disease | Continuous Tremor | 3.19e-04 | 9 | 89 | 2 | C0234371 | |
| Disease | Darkness Tremor | 3.19e-04 | 9 | 89 | 2 | C0234381 | |
| Disease | Involuntary Quiver | 3.19e-04 | 9 | 89 | 2 | C1527384 | |
| Disease | Tremor, Perioral | 3.19e-04 | 9 | 89 | 2 | C0235078 | |
| Disease | Nerve Tremors | 3.19e-04 | 9 | 89 | 2 | C0235083 | |
| Disease | Tremor, Limb | 3.19e-04 | 9 | 89 | 2 | C0235081 | |
| Disease | Tremor, Muscle | 3.19e-04 | 9 | 89 | 2 | C0235082 | |
| Disease | Senile Tremor | 3.19e-04 | 9 | 89 | 2 | C0149840 | |
| Disease | Saturnine Tremor | 3.19e-04 | 9 | 89 | 2 | C0040827 | |
| Disease | Pill Rolling Tremor | 3.19e-04 | 9 | 89 | 2 | C0751564 | |
| Disease | Tremor, Semirhythmic | 3.19e-04 | 9 | 89 | 2 | C0751565 | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 3.19e-04 | 9 | 89 | 2 | EFO_0800562 | |
| Disease | X-21467 measurement | 3.19e-04 | 9 | 89 | 2 | EFO_0020007 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 3.98e-04 | 10 | 89 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 3.98e-04 | 10 | 89 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 3.98e-04 | 10 | 89 | 2 | EFO_0022090 | |
| Disease | sleep disorder (implicated_via_orthology) | 4.86e-04 | 11 | 89 | 2 | DOID:535 (implicated_via_orthology) | |
| Disease | Tremor | 4.86e-04 | 11 | 89 | 2 | C0040822 | |
| Disease | androstenediol (3beta,17beta) monosulfate (2) measurement | 4.86e-04 | 11 | 89 | 2 | EFO_0800295 | |
| Disease | Lenticulostriate Disorders | 5.82e-04 | 12 | 89 | 2 | C0750951 | |
| Disease | Extrapyramidal Disorders | 5.82e-04 | 12 | 89 | 2 | C0015371 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 5.82e-04 | 12 | 89 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Basal Ganglia Diseases | 5.82e-04 | 12 | 89 | 2 | C0004782 | |
| Disease | ecosanoids measurement | 6.21e-04 | 55 | 89 | 3 | EFO_0020044 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 6.87e-04 | 13 | 89 | 2 | EFO_0800474 | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 6.87e-04 | 13 | 89 | 2 | EFO_0800293 | |
| Disease | 5alpha-pregnan-3beta,20beta-diol monosulfate (1) measurement | 6.87e-04 | 13 | 89 | 2 | EFO_0800284 | |
| Disease | X-21470 measurement | 8.00e-04 | 14 | 89 | 2 | EFO_0800817 | |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 1.05e-03 | 16 | 89 | 2 | C0751885 | |
| Disease | Drug-induced agranulocytosis | 1.05e-03 | 16 | 89 | 2 | HP_0012235 | |
| Disease | Pheochromocytoma, Extra-Adrenal | 1.05e-03 | 16 | 89 | 2 | C1257877 | |
| Disease | obstructive sleep apnea | 1.06e-03 | 66 | 89 | 3 | EFO_0003918 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 1.19e-03 | 17 | 89 | 2 | C0751883 | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 1.33e-03 | 18 | 89 | 2 | EFO_0800288 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 1.49e-03 | 19 | 89 | 2 | C0751884 | |
| Disease | metabolonic lactone sulfate measurement | 1.49e-03 | 19 | 89 | 2 | EFO_0800659 | |
| Disease | Pheochromocytoma | 1.49e-03 | 19 | 89 | 2 | C0031511 | |
| Disease | sphingomyelin measurement | 1.56e-03 | 278 | 89 | 5 | EFO_0010118 | |
| Disease | cerebellum white matter volume change measurement, age at assessment | 1.65e-03 | 20 | 89 | 2 | EFO_0008007, EFO_0021498 | |
| Disease | Nephritis, Tubulointerstitial | 1.82e-03 | 21 | 89 | 2 | C0041349 | |
| Disease | 5alpha-androstan-3beta,17beta-diol disulfate measurement | 2.00e-03 | 22 | 89 | 2 | EFO_0021115 | |
| Disease | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 2.18e-03 | 23 | 89 | 2 | C1708353 | |
| Disease | Nephritis, Interstitial | 2.38e-03 | 24 | 89 | 2 | C0027707 | |
| Disease | Myasthenic Syndromes, Congenital | 2.38e-03 | 24 | 89 | 2 | C0751882 | |
| Disease | partial thromboplastin time | 2.38e-03 | 24 | 89 | 2 | EFO_0004310 | |
| Disease | Noonan Syndrome | 2.38e-03 | 24 | 89 | 2 | C0028326 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TISFVSYILSLFPSP | 11 | Q9Y3F1 | |
| PALALYVFTIATEPL | 16 | Q8WW43 | |
| IFRSSCPISVTYFPF | 146 | Q07001 | |
| ALLFVLLSPVGPYFS | 181 | P54687 | |
| FGLIPSPSVYLVASF | 896 | Q5SY80 | |
| HLYFTLNPRFISVFP | 386 | Q6UX41 | |
| AFKPFFVDLTLPYSV | 786 | A8K2U0 | |
| IFSQADPSPLLFYLC | 331 | O15085 | |
| PLFLYPFLHTVSKTR | 116 | Q92600 | |
| ILLYSFSVPESLFPG | 216 | Q96LT6 | |
| LPRFISLYIFSFLSP | 81 | Q008S8 | |
| IPCVLISFLAPLSFY | 246 | Q9UGM1 | |
| ISFLAPLSFYLPAAS | 251 | Q9UGM1 | |
| PTFYLVCFLTPVVAL | 1296 | O94823 | |
| VCFLTPVVALLPRYF | 1301 | O94823 | |
| LAALYTIVAVFPSPL | 926 | Q9Y2K5 | |
| ATTYAVLTPFLSPII | 276 | O60403 | |
| YTVITPFLSPIIFSL | 291 | Q8NGY0 | |
| PLFIIVLASFTYLSF | 106 | Q86WK9 | |
| FASYAFAPLSLIVPL | 91 | Q6P499 | |
| FFLYVLESLPSPTLT | 116 | P19256 | |
| SPFLILPLTFYHVVD | 246 | P78508 | |
| RSHFFLPVSVVYVPI | 41 | Q9GZQ4 | |
| VPFVLLSIKPSLTFY | 431 | Q6ZWT7 | |
| NPLIYCVFSSSISFP | 326 | Q6W5P4 | |
| SGLSPPVAIFFVIYT | 281 | Q9HB07 | |
| LDPFFLSITVFPFLI | 216 | P08684 | |
| FPPVSLYGLTLFSAS | 881 | Q9H6A9 | |
| LDVFLSAFYTVVPPT | 271 | Q8NHC6 | |
| HILFSSIYLLVPPFL | 276 | Q9UKL2 | |
| PFTISPLDKFLAIFY | 261 | Q8NGD3 | |
| PLDKFLAIFYTVFTP | 266 | Q8NGD3 | |
| LLSVFYTIFTPLLNP | 271 | Q8NGD5 | |
| FHTVIFPLLNPIIYT | 276 | Q8NGD0 | |
| PCIFIYARPFSTFSV | 251 | P0C623 | |
| LADIPVTICTYPFVF | 651 | Q5GLZ8 | |
| LVSYTTLPAIFIPFF | 211 | O95237 | |
| LVAPVPHSFYSFELI | 466 | Q8WVZ9 | |
| TTFVTPLLNPFIYAL | 281 | Q8NH40 | |
| LFCIPFQATVYALPT | 86 | P47211 | |
| TTPIAFVKDILFPYI | 21 | Q9UHY7 | |
| PSRICSSAPLLYFLF | 946 | Q93033 | |
| SSAPLLYFLFICPFV | 951 | Q93033 | |
| DAKFFFIPLSYLPTS | 286 | O14756 | |
| YTDTFLPFIHTICPL | 291 | Q9NZS9 | |
| TFPSTRLPLTLVYCF | 276 | Q8WUS8 | |
| LRDIPFSIIYFPLFA | 191 | Q9H1K4 | |
| FAFLVSPSPYELCAV | 481 | P10635 | |
| IILFVFDLPAYTSPT | 1856 | Q9BZC7 | |
| YTSPTNFPAVLSLFL | 1866 | Q9BZC7 | |
| LYKFFAPALISVSLP | 241 | Q92674 | |
| ILLTAYFVIQPFSPL | 71 | Q6UWU4 | |
| ATAFLFIIEPPYFTA | 376 | Q7Z5N4 | |
| ILAPFLEYFSTCLFP | 361 | A6NIM6 | |
| LCASYPIPIILFTGF | 21 | Q12770 | |
| ASFSVPYALTLSFPL | 646 | Q9Y2J2 | |
| LFFVPCIFIYVRPVS | 246 | Q8NH83 | |
| SIIASPFLGSPVYFF | 46 | P0C604 | |
| PTLASPVYFFLANLS | 51 | Q8NH37 | |
| ALFFVPCIFTYVHPF | 246 | Q8NH37 | |
| SIAFLSPIFLTITPF | 46 | Q9H720 | |
| AIIFSYPSTHPFILI | 266 | P59541 | |
| AIIFSYPSTHPFILI | 266 | P0DTE0 | |
| AIAFSYPSTHPFILI | 266 | P59540 | |
| KALLTTYGFPSPIFL | 46 | Q76EJ3 | |
| SRYLPAHFSPLVFFL | 211 | Q9NQ40 | |
| SPAIFLYLISIVPSL | 66 | Q6ZUK4 | |
| SATPALYLLSPFSVV | 106 | P35499 | |
| AYSSFVIPFIHLPEI | 326 | Q7RTX9 | |
| QSLPLLVPFSCTFGY | 371 | Q6ZSM3 | |
| AFAPTFPVYCVLRFL | 191 | Q63ZE4 | |
| TFGYPPLTKILASFF | 66 | Q16773 | |
| FYLISPLDFVPEALF | 211 | Q96K19 | |
| LLASVPPVFGLYTSF | 46 | Q8NG04 | |
| AFLPFISYPQILTLS | 131 | P27930 | |
| HLGLPFSFLTFPYVE | 146 | P49908 | |
| GLFSIISSIPFFFLP | 266 | Q9Y6L6 | |
| TYVTIFIPALPATFL | 156 | Q96FL8 | |
| IFPDAYTLTFIPVIS | 296 | Q499Z3 | |
| IFESDIPFIFTFLIP | 1156 | O94911 | |
| PTITFGTAIAAFYIP | 191 | P08912 | |
| TTGHYSLFPLLFTAP | 411 | Q9BVK2 | |
| FVISFFPSLIYPLQV | 81 | G3V211 | |
| LLACFFAPISVIPTY | 331 | Q9UBH6 | |
| LLPCFYFVELPILAS | 66 | Q7Z2D5 | |
| SGFEYTICFLPPLVL | 61 | Q9UBS8 | |
| FFLVYSLVVILPKTP | 201 | Q86W33 | |
| YPALIPITTASFIAA | 116 | Q5BJH2 | |
| SYLAPPVSAVFVLAL | 461 | P31639 | |
| TLLPCFYFVELPIVA | 16 | Q6T4P5 | |
| FTLRHFIVYPPESAV | 56 | Q9P227 | |
| GLFSIISSIPFFFLP | 266 | Q9NPD5 | |
| LTPEFFYLPEFLTNC | 2691 | Q6ZS81 | |
| PYLFHVVTFLVATGP | 2101 | P21359 | |
| FSATPALYILSPFNL | 106 | Q9UQD0 | |
| PYKVFLSFPLATIVI | 391 | Q8TCU3 | |
| AIFPLVYAIPLALST | 211 | Q9Y5Z9 | |
| FPLLTVYLKVFLSPT | 116 | P07949 | |
| TLQLFFDLYHSIPPS | 261 | Q9UIA9 | |
| LLSYPLPFFAAVEVL | 391 | Q9H598 | |
| LAPVFALFVPFYCSI | 131 | Q8NBM4 | |
| PPELVLYSLVFVLFC | 766 | Q7Z2W7 | |
| AFFCPPLIYTRLITF | 696 | Q8TD43 | |
| PALFTIITFPFLFAV | 396 | Q9Y487 | |
| LALVPTPALFYLFTA | 281 | Q9P055 | |
| TPALFYLFTAKFTEP | 286 | Q9P055 |